Literature DB >> 6258979

Autocatalytic phosphorylation of calsequestrin.

M Varsànyi, L M Heilmeyer.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6258979     DOI： 10.1016/0014-5793(80)80444-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

1.  Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels.

Authors:  Nicole A Beard; Magdalena M Sakowska; Angela F Dulhunty; Derek R Laver
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

2.  Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation.

Authors:  Nicole A Beard; Marco G Casarotto; Lan Wei; Magdolna Varsányi; Derek R Laver; Angela F Dulhunty
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

3.  Calsequestrin: more than 'only' a luminal Ca2+ buffer inside the sarcoplasmic reticulum.

Authors:  C Szegedi; S Sárközi; A Herzog; I Jóna; M Varsányi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

4.  Phosphorylation of human calsequestrin: implications for calcium regulation.

Authors:  Emiliano J Sanchez; Gerhard R Munske; Angela Criswell; Hendrik Milting; A Keith Dunker; Chulhee Kang
Journal:  Mol Cell Biochem       Date:  2011-03-17       Impact factor: 3.396

5.  Glycosylation of skeletal calsequestrin: implications for its function.

Authors:  Emiliano J Sanchez; Kevin M Lewis; Gerhard R Munske; Mark S Nissen; ChulHee Kang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

6.  Characterization of Post-Translational Modifications to Calsequestrins of Cardiac and Skeletal Muscle.

Authors:  Kevin M Lewis; Gerhard R Munske; Samuel S Byrd; Jeehoon Kang; Hyun-Jai Cho; Eduardo Ríos; ChulHee Kang
Journal:  Int J Mol Sci       Date:  2016-09-13       Impact factor: 5.923

Review 7.  Calsequestrin: a well-known but curious protein in skeletal muscle.

Authors:  Jin Seok Woo; Seung Yeon Jeong; Ji Hee Park; Jun Hee Choi; Eun Hui Lee
Journal:  Exp Mol Med       Date:  2020-12-07       Impact factor: 8.718
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.